Petron and the Healthcare Debate::The public option as a signal – Paul Krugman Blog – NYTimes.com

When petron was a government owned company, they were able to distort the supply curves because they were in essence the regulatory arm of the government. If the outcry was large enough shell and caltex may increase their prices but petron’s price does not move. What’s interesting in the case of the philippines is that […]

READ MORE